Eleven Biotherapeutics, Roche deal

Eleven granted Roche exclusive, worldwide rights to develop and commercialize EBI-031, a mAb

Read the full 130 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE